The global demand for Indian generic medicines continues to surge in 2026, driven by India’s position as the “Pharmacy of the World” — supplying over 20% of the world’s generic medicines by volume. However, alongside legitimate manufacturers and exporters, the market also contains unverified intermediaries and counterfeit operators. For international buyers, knowing how to verify a supplier’s credentials is the single most important step before making a purchasing decision.
This guide provides a practical, step-by-step framework for verifying Indian generic medicine suppliers — from license checks to physical audits — helping buyers minimize risk and source with confidence.
🇮🇳 Why Supplier Verification Matters in 2026
India’s pharmaceutical export market reached an estimated $28 billion in FY2025–26, according to Pharmexcil data, with exports to over 200 countries. The industry includes more than 3,000 pharmaceutical companies and approximately 10,500 manufacturing units — of which only about 2,000 are WHO-GMP certified.
This gap between total manufacturers and certified facilities creates room for substandard players. Recent investigative reports have highlighted quality concerns at certain facilities producing GLP-1 generics (India Today, July 2026), underscoring the need for rigorous supplier due diligence. The CDSCO’s strengthened Schedule M (revised 2025) now mandates stricter quality management systems, but enforcement remains uneven across smaller units.
Key risks of engaging with unverified suppliers include:
- Substandard or counterfeit products — medicines that fail quality tests or contain incorrect active ingredients
- Regulatory seizure — customs authorities may confiscate shipments lacking proper documentation
- Legal liability — importing unregistered medicines can result in fines or criminal charges in your country
- Patient safety risks — the most serious consequence of compromised medicines
✅ Step 1: Verify CDSCO Manufacturing License
Every legitimate pharmaceutical manufacturer in India must hold a valid manufacturing license issued by the Central Drugs Standard Control Organization (CDSCO) or the respective State Drug Controller. This is the foundational credential — if a supplier cannot provide this, do not proceed.
How to verify:
- Request a copy of the Form 25 (manufacturing license) or Form 28 (loan license) — these are issued under the Drugs and Cosmetics Act, 1940
- Cross-check the license number with the State Drug Controller’s office in the state where the facility is registered (e.g., Maharashtra FDA, Gujarat FDA, Telangana Drugs Control Administration)
- Verify that the license covers the specific dosage forms you intend to purchase — tablets, capsules, injectables, liquids, etc.
- Check the expiry date of the license — expired licenses are not valid
The CDSCO maintains a public database of licensed manufacturers at cdscoonline.gov.in, though not all state-level licenses are reflected in the central portal — direct verification with the state authority is recommended.
🛡️ Step 2: Confirm WHO-GMP Certification
WHO-Good Manufacturing Practices (WHO-GMP) certification is the most widely recognized quality benchmark for Indian pharmaceutical exports. Without it, your shipment may be rejected at destination customs in many regulated markets.
Verification checklist:
- Request the WHO-GMP certificate issued by the State Drug Controller — it must include the certificate number, facility address, product categories, and validity period
- Cross-verify with the CDSCO state licensing authority — WHO-GMP certifications are issued after physical inspection of the facility
- Check that the certification has not expired — WHO-GMP certificates are typically valid for 3 years from the date of inspection
- For European markets, check for EU-GMP equivalency — many Indian manufacturers hold separate EU-GMP certificates issued after inspection by European regulators
India had approximately 2,025 WHO-GMP compliant manufacturing units as of March 2026, representing only about 19% of total registered pharma manufacturing units in the country. This statistic alone underscores the importance of checking WHO-GMP status.
🔍 Step 3: Verify Export Credentials and Import-Export Code (IEC)
Any company exporting pharmaceuticals from India must possess a valid Import-Export Code (IEC) issued by the Directorate General of Foreign Trade (DGFT). Additionally, the company should be registered with Pharmexcil (Pharmaceuticals Export Promotion Council of India), the official body under the Ministry of Commerce.
Verification steps:
- Ask for the IEC number and verify it on the DGFT website (dgft.gov.in) — the IEC should show the company’s legal name, address, and validity status
- Confirm Pharmexcil registration — a registered RCMC (Registration-cum-Membership Certificate) number confirms the company is an approved pharma exporter
- Request past export invoices and bills of lading — these prove actual export history and experience
📋 Step 4: Request and Verify Product-Specific Documentation
For the specific products you intend to purchase, request the following documentation from the supplier:
- Certificate of Analysis (CoA) — for each batch, showing active ingredient potency, purity, dissolution profile, and impurity levels
- Stability data — at minimum, accelerated stability studies (6 months) and preferably long-term real-time data
- Product registration certificate — if the product is registered in an export market, the registration document from that country’s regulatory authority
- Free Sale Certificate — issued by the State Drug Controller, confirming the product is approved for sale in India
- Manufacturing batch record — summary of the production process for the specific batch
A reputable supplier will provide these documents promptly. Delays, incomplete documents, or refusal to share documentation are significant red flags.
🚩 Red Flags: Warning Signs of Unverified Suppliers
Experience with international pharmaceutical procurement has identified several common warning signs. Treat any of the following as grounds for heightened scrutiny or immediate disqualification:
- Prices significantly below market — if a quote is 40–60% lower than comparable suppliers, the product quality is likely compromised
- Pressure for immediate payment — legitimate suppliers offer standard payment terms (LC, partial advance, etc.)
- Vague or non-existent company address — verify the physical address via Google Maps or third-party verification services
- No physical inspection allowed — any supplier that refuses or delays facility visits should be disqualified
- Unprofessional communication — generic email domains (@gmail.com, @yahoo.com), poor English suggesting the company lacks professional export capacity
- Claims of “magic” cure products — unsubstantiated therapeutic claims that go beyond approved indications
- No product registration in any regulated market — a company that hasn’t registered products even in their home market may lack regulatory competence
🌐 Step 5: Use Industry Directories and Trade Associations
One of the most reliable ways to find verified suppliers is through established industry associations and directories. These organizations pre-screen their members and provide an additional layer of trust.
Recommended resources:
- IMSDA (Indian Medicine Supplier and Distributors Association) — the organization behind this site provides a curated IMSDA’s verified member directory of reliable pharmaceutical distributors and suppliers
- Pharmexcil — maintains a searchable database of registered pharma exporters at pharmexcil.org
- IDMA (Indian Drug Manufacturers’ Association) — membership directory of established manufacturers
- CII and FICCI — industry chamber directories that list reputable pharmaceutical companies
- WHO Prequalification list — products that have passed WHO prequalification are verified for United Nations procurement
For a list of verified and reliable pharmaceutical distributors, refer to the IMSDA’s verified member directory, which connects buyers with pre-vetted Indian pharmaceutical suppliers.
🔬 Step 6: Conduct Independent Lab Testing (For Critical Orders)
For large or critical orders, consider independent third-party lab testing of a sample batch before committing to full-scale purchasing. This is especially important for:
- First-time orders from a new supplier
- High-value therapeutic categories — oncology, cardiovascular, immunosuppressants, GLP-1 agonists
- Temperature-sensitive products — insulins, biologics, biosimilars
- Products destined for regulated markets — the EU, US, UK, Australia, Japan
Reputable Indian labs for pharmaceutical testing include:
- National Accreditation Board for Testing and Calibration Laboratories (NABL)-accredited labs — searchable at nabl.qcin.org
- Central Drugs Laboratory (CDL), Kolkata — the government’s apex drug testing laboratory
- Regional Drug Testing Laboratories (RDTLs) — located in Mumbai, Chennai, Hyderabad, and other major cities
- Private NABL-accredited labs such as SGS India, Intertek, and Bureau Veritas
📊 Supplier Verification Checklist (Printable Summary)
Use this quick checklist when evaluating any new Indian generic medicine supplier:
- ☐ CDSCO/State Drug Controller manufacturing license verified
- ☐ WHO-GMP certificate confirmed and within validity
- ☐ Import-Export Code (IEC) validated on DGFT portal
- ☐ Pharmexcil registration (RCMC) confirmed
- ☐ Facility address verified (not a PO box or virtual office)
- ☐ Certificate of Analysis reviewed for target product
- ☐ Past export invoices and references checked
- ☐ Company registered on industry association directories
- ☐ No red flags on pricing, payment terms, or communication
- ☐ Independent lab testing arranged for critical orders
💡 Conclusion
India’s generic medicine industry offers extraordinary value for global healthcare systems, but buyer diligence is essential to separate reliable manufacturers from unverified intermediaries. By systematically checking CDSCO licenses, WHO-GMP certifications, export credentials, and product documentation — and by using trusted directories like the IMSDA member directory — international buyers can source high-quality, affordable medicines with confidence.
The cost of verifying a supplier is minimal compared to the risk of receiving substandard medicines. Invest the time upfront to ensure your supply chain is safe, legal, and reliable.
For more information, contact IMSDA at contact@indiamedicine.org.